IRS1 and Alzheimer disease: The IR developed in the AD brain appears to be related to Aβ plaques and tau pathologies [95], as supported by inhibited brain IRS-1 in patients showing tauopathies [96], wherein Aβ oligomers promote insulin receptor internalization [97].